Justice Department Argues For New Restrictions On Gene Patents
This article was originally published in The Gray Sheet
Executive Summary
In a move that could add uncertainty to biotechnology and diagnostic patents, the U.S. Department of Justice is arguing that isolated genes are not patentable, opposing established policy of the U.S. Patent and Trademark Office.